✦ LIBER ✦

A randomized, double-blind study of OROS hydromorphone extended release (ER) compared to placebo in opioid-tolerant patients with moderate-to-severe osteoarthritis (OA) pain

✍ Scribed by D. Taylor; M. Kutch

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind study of OROS

✍ M. Hale; R. Rauck; S. Li; M. Kutch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 34 KB

Efficacy and tolerability of OROS hydrom

✍ M. Hale; J. Patrick; S. Nalamachu 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 34 KB

Results of a Double-blind, Placebo-contr

✍ Richard Rauck; Ronald Rapoport; John Thipphawong 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB

Sustained Safety and Efficacy of Once-Da

✍ Ute Richarz; Sandra Waechter; Rainer Sabatowski; Leszek Szczepanski; Heinrich Bi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB

Efficacy and Safety of OPANA ER (Oxymorp

✍ Martin E. Hale; Harry Ahdieh; Tina Ma; Richard Rauck 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 317 KB

Safety and Tolerability of Once-Daily OR

✍ Srinivas R. Nalamachu; Michael Kutch; Martin E. Hale 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 172 KB